Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients

NACompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2012

Conditions
Cytomegalovirus
Interventions
BIOLOGICAL

depistage

Virus isolation from urine, blood, or any suitable sample in case of CMV disease Resistance phenotype to antivirals UL97 and UL54 genes sequencing from blood, urines or any suitable samples for resistance mutations detection and polymorphism study

Trial Locations (33)

14

Virologie, Caen

21

Virologie, Dijon

25

Virologie, Besançon

29

Virologie, Brest

30

Virologie, Nîmes

31

Virologie, Toulouse

33

Virologie, Bordeaux

34

Virologie, Montpellier

35

Virologie, Rennes

37

Virologie, Tours

38

Virologie, Grenoble

42

Virologie, Saint-Etienne

44

Virologie, Nantes

49

Virologie, Angers

51

Virologie, Reims

54

Virologie, Nancy

59

Virologie, Lille

63

Virologie, Clermont-Ferrand

67

Virologie, Strasbourg

69

Virologie, Lyon

75

Virologie - Hôpital BICHAT, Paris

Virologie - Hôpital La Pitié Salpétrière, Paris

Virologie - Hôpital LARIBOISIERE, Paris

Virologie - Hôpital NECKER, Paris

Virologie - Hôpital SAINT-LOUIS, Paris

76

Virologie, Rouen

80

Virologie, Amiens

86

Virologie, Poitiers

92

Virologie, Suresne

93

Virologie - Hôpital Avicenne, Bobigny

94

Virologie - Hôpital Paul Brousse, Villejuif

97

Virologie, Fort de France

87042

Bactériologie Virologie, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT01008540 - Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients | Biotech Hunter | Biotech Hunter